10-K/APeriod: FY2014

FREEPORT-MCMORAN INC Annual Report (Amendment), Year Ended Dec 31, 2014

Filed June 12, 2015For Securities:FCX

Summary

This filing is an amendment (10-K/A) to Freeport-McMoRan Inc.'s (FCX) 2014 Annual Report, primarily to file revised redacted versions of Exhibits 10.23 and 10.24 due to changes in their confidential treatment request. No other substantive changes or updates to the original filing's disclosures are made; this amendment does not reflect events after the original filing date of February 27, 2015. Investors should refer to the original 10-K filing for comprehensive financial and operational information for the fiscal year ended December 31, 2014. As an amendment, this document does not introduce new financial statements or update Item 307/308 disclosures. New certifications from the principal executive and financial officers are included as required by Rule 13a-14(a), though certain paragraphs are omitted as they pertain to financial statements or specific disclosures not amended here. For a full understanding of FCX's performance and outlook, investors should consult the original Form 10-K.

Financial Highlights

50 data points
Beta

Revenue

$21.44B

9.0% Gross Margin

Net Income

-$1.31B

-6.1% Net Margin

EPS (Diluted)

$-1.26

Total Assets

$58.67B

Cash & Equivalents

$298.00M

Free Cash Flow

$5.63B

Financial Statements
Beta
Revenue$21.44B
Cost of Revenue$19.50B
Gross Profit$1.93B
SG&A Expenses$580.00M
Operating Expenses$20.30B
Operating Income-$298.00M
Net Income-$1.31B
EPS (Basic)$-1.26
EPS (Diluted)$-1.26
Shares Outstanding (Basic)1.04B
Shares Outstanding (Diluted)1.04B

Key Highlights

  • 1This document is an amendment (10-K/A) to the previously filed 2014 Annual Report on Form 10-K.
  • 2The primary purpose of this amendment is to file revised, redacted versions of Exhibits 10.23 and 10.24.
  • 3These exhibit revisions are due to changes in FCX's confidential treatment request for certain information within those exhibits.
  • 4No other substantive changes, financial statement updates, or operational disclosures from the original 2014 10-K filing have been made.
  • 5This amendment does not reflect events or information subsequent to the original filing date (February 27, 2015).
  • 6New certifications from FCX's principal executive and financial officers are included as required by SEC rules.
  • 7Investors should review the original Form 10-K filing for comprehensive information regarding FCX's 2014 fiscal year.

Frequently Asked Questions

The main purpose of this filing is to submit revised, redacted versions of Exhibits 10.23 and 10.24 due to an updated confidential treatment request for information contained within them. It is an amendment to the original 2014 Form 10-K.

No, this amendment does not contain updated financial statements or new financial information. It is solely for the purpose of filing revised exhibits and does not alter the financial disclosures of the original 2014 Form 10-K.

No, this amendment explicitly states that it does not reflect events occurring after the original filing date of February 27, 2015, nor does it modify or update disclosures that may be affected by subsequent events. Investors should consult other SEC filings for information beyond the original 2014 report.

No, this filing is administrative in nature, focusing on exhibit redactions and required certifications. It does not introduce new disclosures or business updates beyond what was presented in the original Form 10-K filing for the fiscal year ended December 31, 2014.